1.Proposal for risk control of thoracic surgery during the COVID-19 pandemic
Hui LI ; Bin YOU ; Songlei OU ; Lunxu LIU ; Xiaofei LI ; Lanjun ZHANG ; Keneng CHEN ; Gening JIANG
Chinese Journal of Thoracic and Cardiovascular Surgery 2023;39(1):1-3
With the change of COVID-19 prevention and control strategy in China, the number of COVID-19 cases has increased significantly recently, which has also brought new challenges to the perioperative risk control of thoracic surgery. This paper puts forward several suggestions, aiming to standardize the preoperative screening and evaluation during the COVID-19 period, strictly grasp the indications and timing of surgery, optimize the medical management process, individualize surgical decision-making, and minimize the risk of COVID-19 infection to surgery.
2.Proposal for risk control of thoracic surgery during the COVID-19 pandemic
Hui LI ; Bin YOU ; Songlei OU ; Lunxu LIU ; Xiaofei LI ; Lanjun ZHANG ; Keneng CHEN ; Gening JIANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2023;30(02):159-161
With the change of coronavirus disease 2019 (COVID-19) prevention and control strategy in China, the number of COVID-19 cases has increased significantly recently, which has also brought new challenges to the perioperative risk control of thoracic surgery. This paper puts forward several suggestions, aiming to standardize the preoperative screening and evaluation during the COVID-19 period, strictly grasp the indications and timing of surgery, optimize the medical management process, individualize surgical decision-making, and minimize the risk of COVID-19 infection to surgery.
3.Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer.
Jun NI ; Miao HUANG ; Li ZHANG ; Nan WU ; Chunxue BAI ; Liang'an CHEN ; Jun LIANG ; Qian LIU ; Jie WANG ; Yilong WU ; Fengchun ZHANG ; Shuyang ZHANG ; Chun CHEN ; Jun CHEN ; Wentao FANG ; Shugeng GAO ; Jian HU ; Tao JIANG ; Shanqing LI ; Hecheng LI ; Yongde LIAO ; Yang LIU ; Deruo LIU ; Hongxu LIU ; Jianyang LIU ; Lunxu LIU ; Mengzhao WANG ; Changli WANG ; Fan YANG ; Yue YANG ; Lanjun ZHANG ; Xiuyi ZHI ; Wenzhao ZHONG ; Yuzhou GUAN ; Xiaoxiao GUO ; Chunxia HE ; Shaolei LI ; Yue LI ; Naixin LIANG ; Fangliang LU ; Chao LV ; Wei LV ; Xiaoyan SI ; Fengwei TAN ; Hanping WANG ; Jiangshan WANG ; Shi YAN ; Huaxia YANG ; Huijuan ZHU ; Junling ZHUANG ; Minglei ZHUO
Chinese Journal of Lung Cancer 2021;24(3):141-160
BACKGROUND:
Perioperative treatment has become an increasingly important aspect of the management of patients with non-small cell lung cancer (NSCLC). Small-scale clinical studies performed in recent years have shown improvements in the major pathological remission rate after neoadjuvant therapy, suggesting that it will soon become an important part of NSCLC treatment. Nevertheless, neoadjuvant immunotherapy may be accompanied by serious adverse reactions that lead to delay or cancelation of surgery, additional illness, and even death, and have therefore attracted much attention. The purpose of the clinical recommendations is to form a diagnosis and treatment plan suitable for the current domestic medical situation for the immune-related adverse event (irAE).
METHODS:
This recommendation is composed of experts in thoracic surgery, oncologists, thoracic medicine and irAE related departments (gastroenterology, respirology, cardiology, infectious medicine, hematology, endocrinology, rheumatology, neurology, dermatology, emergency section) to jointly complete the formulation. Experts make full reference to the irAE guidelines, large-scale clinical research data published by thoracic surgery, and the clinical experience of domestic doctors and publicly published cases, and repeated discussions in multiple disciplines to form this recommendation for perioperative irAE.
RESULTS:
This clinical recommendation covers the whole process of prevention, evaluation, examination, treatment and monitoring related to irAE, so as to guide the clinical work comprehensively and effectively.
CONCLUSIONS
Perioperative irAE management is an important part of immune perioperative treatment of lung cancer. With the continuous development of immune perioperative treatment, more research is needed in the future to optimize the diagnosis and treatment of perioperative irAE.
4.Opinions on the reclassification of pulmonary adenocarcinoma in situ in the fifth edition of WHO classification of thoracic tumours
Rusi ZHANG ; Meifang ZHANG ; Shugeng GAO ; Gening JIANG ; Qun WANG ; Xiuyi ZHI ; Lanjun ZHANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2021;28(09):1012-1015
Pulmonary adenocarcinoma in situ is reclassified as precursor glandular lesions in the fifth edition of WHO classification of thoracic tumours, causing widespread attention and heated debate among domestic thoracic oncologists, radiologists, pathologists and surgeons. We would like to comment on the topic and make a few suggestions on the management of pulmonary nodule during lung cancer screening. We are open to all suggestion and welcome debates.
5. Thoughts and principles of diagnosis and treatment of chronic refractory wounds in China
Wei DONG ; Yurui XIAO ; Minjie WU ; Duyin JIANG ; Lanjun NIE ; Yingkai LIU ; Jiajun TANG ; Ming TIAN ; Chunlan WANG ; Lifang HUANG ; Jiaoyun DONG ; Xiaozan CAO ; Fei SONG ; Xiaoyun JI ; Xian MA ; Yutian KANG ; Shuwen JIN ; Chun QING ; Shuliang LU
Chinese Journal of Burns 2018;34(12):868-873
The correct thoughts and principles of diagnosis and treatment of chronic refractory wounds need to be formulated. Through the relevant domestic and international consensus and based on clinical experience, the
6.Shanghai Pulmonary Hospital Experts Consensus on the Management of Ground-Glass Nodules Suspected as Lung Adenocarcinoma (Version 1).
Gening JIANG ; Chang CHEN ; Yuming ZHU ; Dong XIE ; Jie DAI ; Kaiqi JIN ; Yingran SHEN ; Haifeng WANG ; Hui LI ; Lanjun ZHANG ; Shugeng GAO ; Keneng CHEN ; Lei ZHANG ; Xiao ZHOU ; Jingyun SHI ; Hao WANG ; Boxiong XIE ; Lei JIANG ; Jiang FAN ; Deping ZHAO ; Qiankun CHEN ; Liang DUAN ; Wenxin HE ; Yiming ZHOU ; Hongcheng LIU ; Xiaogang ZHAO ; Peng ZHANG ; Xiong QIN
Chinese Journal of Lung Cancer 2018;21(3):147-159
Background and objective As computed tomography (CT) screening for lung cancer becomes more common in China, so too does detection of pulmonary ground-glass nodules (GGNs). Although anumber of national or international guidelines about pulmonary GGNs have been published,most of these guidelines are produced by respiratory, oncology or radiology physicians, who might not fully understand the progress of modern minimal invasive thoracic surgery, and these current guidelines may overlook or underestimate the value of thoracic surgery in the management of pulmonary GGNs. In addition, the management for pre-invasive adenocarcinoma is still controversial. Based onthe available literature and experience from Shanghai Pulmonary Hospital, we composed this consensus about diagnosis and treatment of pulmonary GGNs. For lesions which are considered as adenocarcinoma in situ, chest thin layer CT scan follow-up is recommended and resection can only be adopt in some specific cases and excision should not exceed single segment resection. For lesions which are considered as minimal invasive adenocarcinoma, limited pulmonary resection or lobectomy is recommended. For lesions which are considered as early stage invasive adenocarcinoma, pulmonary resection is recommend and optimal surgical methods depend on whether ground glass component exist, location, volume and number of the lesions and physical status of patients. Principle of management of multiple pulmonary nodules is that primary lesions should be handled with priority, with secondary lesions taking into account.
.
Adenocarcinoma
;
diagnosis
;
diagnostic imaging
;
surgery
;
Adenocarcinoma of Lung
;
China
;
Consensus
;
Hospitals
;
Humans
;
Lung Neoplasms
;
diagnosis
;
diagnostic imaging
;
surgery
;
Physicians
;
psychology
;
Positron Emission Tomography Computed Tomography
;
Practice Guidelines as Topic
;
Retrospective Studies
;
Solitary Pulmonary Nodule
;
diagnosis
;
diagnostic imaging
;
surgery
;
Tomography, X-Ray Computed
7.Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome
International Journal of Pediatrics 2017;44(4):263-266
Hemophagocytic syndrome,also called hemophagocytic lymphohistiocytosis,includes primary hemophagocytic lymphohistiocytosis and secondary hemophagocytic lymphohistiocytosis.Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only effective therapy for familial hemophagocytic lymphohistiocytosis (FHL) and refractory EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH),but the differential diagnosis is still difficult.Meanwhile,much more complications and high mortality have attracted attention of many researchers.In this review,the recent advance in allo-HSCT for FHL and EBV-HLH about diagnosis,conditioning regimen,complication after HSCT,death causes and prognosis has been described.
9.A new non-invasive screening of dysglycaemia
Ling ZHU ; Annan LIU ; Lanjun MA ; Yanyan ZHAO ; Yuehua SONG ; Jie PAN ; Weiwei JIANG ; Janping GAO ; Gang WAN
Chinese Journal of Health Management 2011;05(3):146-149
Objective To assess the efficiency of an iontophoresis-based screening method (EZSCAN) in the detection of impaired glucose tolerance (IGT),diabetes mellitus (DM) and metabolic syndrome (MS).Methods A total of 166 subjects without medical history of dysglycaemia underwent fasting plasma glucose (FPG) and HbA1c measurement and oral glucose tolerance test (OGTT) by using traditional or EZSCAN method.Variance analysis (GLM),SNK analysis,logistic regression analysis,and ROC analysis were used to evaluate the diagnostic value of those screening techniques.Results DM,IGT,normal glucose tolerance (NGT) +MS,and NGT were found in 4,26,25 or 111 participants,respectively.For traditional test,FPG of 7.0 mmol/L showed a lower sensitivity to detect DM (0%).The sensitivity of EZSCAN to detect DM,IGT or MS was 50%,77% and 64%,respectively.Conclusions FPG may have lower sensitivity to detect DM,although EZSCAN could show higher sensitivity to detect IGT,DM,and MS.
10.Relationship between lower urinary tract symptoms and age in elderly males of Beijing
Ming LIU ; Jianye WANG ; Ling ZHU ; Gang WAN ; Lanjun MA ; Yanyan ZHAO ; Jie PAN ; Wei JIANG ; Yuehua SONG ; Jianping GAO
Chinese Journal of Geriatrics 2010;29(11):899-901
Objective To investigate the relationship of lower urinary tract symptoms (LUTS)with ageing in elderly population of Beijing. Methods From January 2010 to July 2010, the males over 40 years of age, who came to take routine health examination in Beijing Hospital, received a questionnaire related to urinary symptoms. Eligible men were classified into age groups spanning 10 years, and the urinary symptoms of each group were analyzed. Results Among the 2357 males who were investigated, the incidence of urinary symptoms increased, and the satisfaction of urinate decreased with ageing. In 40-49 age group, 44.94 % of males owned at least one urinary symptom and 71.47% of males were satisfied with their symptoms. In over-80 age group, these figures were 94.97% and 27.67%, respectively. Each symptom was associated with the satisfaction. Nocturia was the commonest symptom in each age group. Conclusions LUTS are common in elderly males and the incidence increases with ageing. Nocturia is the commonest symptom in elderly males.

Result Analysis
Print
Save
E-mail